Advertisement
Biliary| Volume 167, ISSUE 6, P950-956, June 2020

Postoperative infectious complications caused by multidrug-resistant pathogens in patients undergoing major hepatectomy with extrahepatic bile duct resection

Published:April 14, 2020DOI:https://doi.org/10.1016/j.surg.2020.02.015

      Abstract

      Background

      Few reports have addressed postoperative infectious complications caused by multidrug-resistant pathogens. The aim of this study was to review the surgical outcomes of patients undergoing major hepatectomy with extrahepatic bile duct resection and to clarify the incidence of and the risk factors for postoperative infectious complications caused by multidrug-resistant pathogens.

      Methods

      Medical records of consecutive patients who underwent major hepatectomy with extrahepatic bile duct resection between 2006 and 2017 were retrospectively reviewed.

      Results

      Among 620 study patients, 219 had postoperative infectious complications, including 62 (10.0%) with postoperative infectious complications caused by multidrug-resistant pathogens. The mortality of the 62 patients with postoperative infectious complications caused by multidrug-resistant pathogens was higher (n = 8, 12.9%) than that in the 157 patients with postoperative infectious complications caused by non-multidrug-resistant pathogens(n = 2, 1.3%) (P < .001). With multivariate analysis, the presence of preoperative cholangitis, the extent of liver resection more than 50%, operative time longer than 600 minutes, the amount of blood loss more than 1500 mL, and the presence of postoperative infectious complications caused by multidrug-resistant pathogens were identified as independent risk factors for postoperative death. The presence of multidrug-resistant pathogens in preoperative bile culture, the amount of blood loss greater than 1500 mL, the presence of bile leakage, and pancreatic fistula were identified as independent risk factors for postoperative infectious complications caused by multidrug-resistant pathogens.

      Conclusion

      The incidence of postoperative infectious complications caused by multidrug-resistant pathogens in patients undergoing major hepatectomy with extrahepatic bile duct resection is high, approximately 10%. This troublesome complication is closely associated with postoperative death. Thus, preventing postoperative infectious complications caused by multidrug-resistant pathogens is an urgent task to improve surgical outcome after major hepatectomy with extrahepatic bile duct resection.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nagino M.
        • Ebata T.
        • Yokoyama Y.
        • et al.
        Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections.
        Ann Surg. 2013; 258: 129-140
        • Sugawara G.
        • Yokoyama Y.
        • Ebata T.
        • et al.
        Duration of antimicrobial prophylaxis in patients undergoing major hepatectomy with extrahepatic bile duct resection: a randomized controlled trial.
        Ann Surg. 2018; 267: 142-148
        • Neuhaus P.
        • Thelen A.
        • Jonas S.
        • et al.
        Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.
        Ann Surg Oncol. 2012; 19: 1602-1608
        • Farid S.G.
        • White A.
        • Khan N.
        • Toogood G.J.
        • Prasad K.R.
        • Lodge J.P.
        Clinical outcomes of left hepatic trisectionectomy for hepatobiliary malignancy.
        Br J Surg. 2016; 103: 249-256
        • Kusachi S.
        • Sumiyama Y.
        • Nagao J.
        • et al.
        New methods of control against postoperative methicillin-resistant Staphylococcus aureus infection.
        Surg Today. 1999; 29: 724-729
        • Reygaert W.
        Methicillin-resistant Staphylococcus aureus (MRSA): Prevalence and epidemiology issues.
        Clin Lab Sci. 2009; 22: 111-114
        • Sadamori H.
        • Yagi T.
        • Shinoura S.
        • et al.
        Risk factors for organ/space surgical site infection after hepatectomy for hepatocellular carcinoma in 359 recent cases.
        J Hepatobiliary Pancreat Sci. 2013; 20: 186-196
        • Nitta H.
        • Beppu T.
        • Itoyama A.
        • et al.
        Poor outcomes after hepatectomy in patients with ascites infected by methicillin-resistant staphylococci.
        J Hepatobiliary Pancreat Sci. 2015; 22: 166-176
        • Hochwald S.N.
        • Burke E.C.
        • Jarnagin W.R.
        • Fong Y.
        • Blumgart L.H.
        Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma.
        Arch Surg. 1999; 134: 261-266
        • Sugawara G.
        • Yokoyama Y.
        • Ebata T.
        • et al.
        Preoperative biliary colonization/infection caused by multidrug-resistant (MDR) pathogens in patients undergoing major hepatectomy with extrahepatic bile duct resection.
        Surgery. 2018; 163: 1106-1113
        • Ebata T.
        • Yokoyama Y.
        • Igami T.
        • et al.
        Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients.
        Ann Surg. 2012; 256: 297-305
        • Kawashima H.
        • Itoh A.
        • Ohno E.
        • et al.
        Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy and risk factors related to complications.
        Ann Surg. 2013; 257: 121-127
        • Sugawara G.
        • Ebata T.
        • Yokoyama Y.
        • et al.
        The effect of preoperative biliary drainage on infectious complications after hepatobiliary resection with cholangiojejunostomy.
        Surgery. 2013; 153: 200-210
        • Kamiya S.
        • Nagino M.
        • Kanazawa H.
        • et al.
        The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microflora.
        Ann Surg. 2004; 239: 510-517
        • Sugawara G.
        • Nagino M.
        • Nishio H.
        • et al.
        Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial.
        Ann Surg. 2006; 244: 706-714
        • Igami T.
        • Ebata T.
        • Yokoyama Y.
        • Sugawara G.
        • Takahashi Y.
        • Nagino M.
        Portal vein embolization using absolute ethanol: evaluation of its safety and efficacy.
        J Hepatobiliary Pancreat Sci. 2014; 21: 676-681
        • Yokoyama Y.
        • Nishio H.
        • Ebata T.
        • Igami T.
        • Sugawara G.
        • Nagino M.
        Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer.
        Br J Surg. 2010; 97: 1260-1268
        • Ebata T.
        • Mizuno T.
        • Yokoyama Y.
        • Igami T.
        • Sugawara G.
        • Nagino M.
        Surgical resection for Bismuth type IV perihilar cholangiocarcinoma.
        The British journal of surgery. 2018; 105: 829-838
        • Nagino M.
        • Nimura Y.
        • Nishio H.
        • et al.
        Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases.
        Ann Surg. 2010; 252: 115-123
        • Nagino M.
        • Nishio H.
        • Ebata T.
        • Yokoyama Y.
        • Igami T.
        • Nimura Y.
        Intrahepatic cholangiojejunostomy following hepatobiliary resection.
        Br J Surg. 2007; 94: 70-77
        • Classen D.C.
        • Evans R.S.
        • Pestotnik S.L.
        • Horn S.D.
        • Menlove R.L.
        • Burke J.P.
        The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection.
        N Engl J Med. 1992; 326: 281-286
        • Page C.P.
        • Bohnen J.M.
        • Fletcher J.R.
        • McManus A.T.
        • Solomkin J.S.
        • Wittmann D.H.
        Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care.
        Arch Surg. 1993; 128: 79-88
        • Kanazawa H.
        • Nagino M.
        • Kamiya S.
        • et al.
        Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy.
        Langenbeck’s Archives Surg. 2005; 390: 104-113
        • Magiorakos A.P.
        • Srinivasan A.
        • Carey R.B.
        • et al.
        Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.
        Clin Microbiol Infect. 2012; 18: 268-281
        • Mangram A.J.
        • Horan T.C.
        • Pearson M.L.
        • Silver L.C.
        • Jarvis W.R.
        Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee.
        Am J Infect Control. 1999; 27 (quiz 133-134; discussion 96): 97-132
        • Shigeta H.
        • Nagino M.
        • Kamiya J.
        • et al.
        Bacteremia after hepatectomy: an analysis of a single-center, 10-year experience with 407 patients.
        Langenbeck’s Arch Surg. 2002; 387: 117-124
        • Wada K.
        • Takada T.
        • Kawarada Y.
        • et al.
        Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines.
        J Hepatobiliary Pancreat Surg. 2007; 14: 52-58
        • Rahbari N.N.
        • Garden O.J.
        • Padbury R.
        • et al.
        Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS).
        Surgery. 2011; 149: 713-724
        • Bassi C.
        • Dervenis C.
        • Butturini G.
        • et al.
        Postoperative pancreatic fistula: an international study group (ISGPF) definition.
        Surgery. 2005; 138: 8-13
        • Dindo D.
        • Demartines N.
        • Clavien P.A.
        Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.
        Ann Surg. 2004; 240: 205-213
        • Hagihara M.
        • Kusachi S.
        • Kato Y.
        • et al.
        Current status of post-operative infections due to antimicrobial-resistant bacteria after digestive tract surgery in Japan: Japan Postoperative Infectious Complications Survey in 2015 (JPICS'15).
        Surg Today. 2020; 50: 56-67
        • Olthof P.B.
        • Coelen R.J.
        • Wiggers J.K.
        • Besselink M.G.
        • Busch O.R.
        • van Gulik T.M.
        External biliary drainage following major liver resection for perihilar cholangiocarcinoma: impact on development of liver failure and biliary leakage.
        HPB (Oxford). 2016; 18: 348-353
        • Noji T.
        • Okamura K.
        • Tanaka K.
        • et al.
        Surgical technique and results of intrapancreatic bile duct resection for hilar malignancy (with video).
        HPB (Oxford). 2018; 20: 1145-1149
        • Watanabe N.
        • Ebata T.
        • Yokoyama Y.
        • et al.
        Postoperative pancreatic fistula in surgery for perihilar cholangiocarcinoma.
        World J Surg. 2019; 43: 3094-3100
        • Okamura K.
        • Tanaka K.
        • Miura T.
        • et al.
        Randomized controlled trial of perioperative antimicrobial therapy based on the results of preoperative bile cultures in patients undergoing biliary reconstruction.
        J Hepatobiliary Pancreat Sci. 2017; 24: 382-393